Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_assertion type Assertion NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_head.
- NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_assertion wasGeneratedBy ECO_0000203 NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_provenance.
- NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_assertion wasDerivedFrom befree-20150227 NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_provenance.
- NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_assertion SIO_000772 21805029 NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_provenance.
- NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_assertion evidence source_evidence_literature NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_provenance.
- NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_assertion description "[In conclusion, our results demonstrate the ability of hydralazine and valproate to increase the NK activity against epithelial cancer cell lines and suggest that these drugs could reduce the levels of soluble MICA and MICB helping in avoiding tumor-induced suppression of NK cytotoxicity against the tumor.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1014972.RA-BhVVTsODUvIj9JJZS2WP3Y-y4M3-E2kNJzVRDwxYQM130_provenance.